Total Payments
$10,880
2024 Payments
$5,455
Companies
2
Transactions
20
Medicare Patients
784
Medicare Billing
$119,461

Payment Breakdown by Category

Consulting$10,850 (99.7%)
Education$30.00 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $10,850 18 99.7%
Education $30.00 2 0.3%

Top Paying Companies

Company Total Records Latest Year
VERTEX PHARMACEUTICALS INCORPORATED $10,850 18 $0 (2024)
Alexion Pharmaceuticals, Inc. $30.00 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,455 8 VERTEX PHARMACEUTICALS INCORPORATED ($5,425)
2023 $2,625 6 Vertex Pharmaceuticals Incorporated ($2,625)
2022 $525.00 1 Vertex Pharmaceuticals Incorporated ($525.00)
2021 $1,575 4 Vertex Pharmaceuticals Incorporated ($1,575)
2020 $700.00 1 VERTEX PHARMACEUTICALS INCORPORATED ($700.00)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/10/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $350.00 General
10/10/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $175.00 General
10/09/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $2,800.00 General
09/05/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Education In-kind items and services $15.00 General
Category: Rare Disease
08/06/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Education In-kind items and services $15.00 General
Category: Rare Disease
06/13/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $1,750.00 General
06/13/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $175.00 General
06/13/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $175.00 General
08/03/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $175.00 General
08/03/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $175.00 General
05/24/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $700.00 General
05/24/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $700.00 General
05/24/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $525.00 General
05/24/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $350.00 General
03/17/2022 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $525.00 General
11/19/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $875.00 General
08/28/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $175.00 General
08/19/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $175.00 General
06/03/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $350.00 General
04/29/2020 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $700.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 47 65 $37,953 $5,244
2022 4 148 221 $108,812 $17,227
2021 7 296 554 $240,748 $54,035
2020 8 293 507 $215,842 $42,955
Total Patients
784
Total Services
1,347
Medicare Billing
$119,461
Procedure Codes
23

All Medicare Procedures & Services

23 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 18 31 $12,400 $1,885 15.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 16 21 $10,605 $1,791 16.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 13 13 $14,948 $1,567 10.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 34 81 $27,360 $5,424 19.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 32 48 $31,232 $4,274 13.7%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 28 28 $20,124 $3,632 18.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 43 49 $24,002 $2,944 12.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 11 15 $6,094 $952.24 15.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 104 198 $75,834 $16,200 21.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 58 123 $58,425 $14,981 25.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 53 150 $48,300 $10,174 21.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 33 34 $20,570 $4,444 21.6%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 21 21 $15,456 $3,445 22.3%
38222 Diagnostic aspirations and biopsies of bone marrow Office 2021 15 15 $13,830 $2,496 18.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 12 13 $8,333 $2,295 27.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 53 137 $65,075 $12,991 20.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 79 136 $52,088 $8,661 16.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 58 117 $37,674 $8,033 21.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 45 48 $29,040 $6,358 21.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 15 19 $12,179 $2,658 21.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 14 14 $10,304 $2,177 21.1%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 15 20 $6,282 $1,383 22.0%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Office 2020 14 16 $3,200 $694.56 21.7%

About Dr. Amy Sharma, MD

Dr. Amy Sharma, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609178706.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Sharma, MD has received a total of $10,880 in payments from pharmaceutical and medical device companies, with $5,455 received in 2024. These payments were reported across 20 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($10,850).

As a Medicare-enrolled provider, Sharma has provided services to 784 Medicare beneficiaries, totaling 1,347 services with total Medicare billing of $119,461. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.

Practice Information

Products in Payments

  • ULTOMIRIS (Biological) $30.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx